- Home
- TITN vs MGNX Comparison
TITN vs MGNX Comparison
Compare TITN & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TITN
- MGNX
- Stock Information
- Founded
- TITN 1980
- MGNX 2000
- Country
- TITN United States
- MGNX United States
- Employees
- TITN N/A
- MGNX N/A
- Industry
- TITN Other Specialty Stores
- MGNX Biotechnology: Pharmaceutical Preparations
- Sector
- TITN Consumer Discretionary
- MGNX Health Care
- Exchange
- TITN Nasdaq
- MGNX Nasdaq
- Market Cap
- TITN 319.6M
- MGNX 257.3M
- IPO Year
- TITN 2007
- MGNX 2013
- Fundamental
- Price
- TITN $14.44
- MGNX $3.57
- Analyst Decision
- TITN Buy
- MGNX Buy
- Analyst Count
- TITN 6
- MGNX 11
- Target Price
- TITN $21.00
- MGNX $8.57
- AVG Volume (30 Days)
- TITN 183.9K
- MGNX 751.3K
- Earning Date
- TITN 11-26-2024
- MGNX 11-05-2024
- Dividend Yield
- TITN N/A
- MGNX N/A
- EPS Growth
- TITN N/A
- MGNX N/A
- EPS
- TITN 2.59
- MGNX N/A
- Revenue
- TITN $2,808,622,000.00
- MGNX $141,329,000.00
- Revenue This Year
- TITN N/A
- MGNX $119.63
- Revenue Next Year
- TITN N/A
- MGNX N/A
- P/E Ratio
- TITN $5.58
- MGNX N/A
- Revenue Growth
- TITN 13.99
- MGNX 16.68
- 52 Week Low
- TITN $12.30
- MGNX $2.95
- 52 Week High
- TITN $29.30
- MGNX $21.88
- Technical
- Relative Strength Index (RSI)
- TITN 50.29
- MGNX 44.98
- Support Level
- TITN $14.19
- MGNX $3.63
- Resistance Level
- TITN $15.45
- MGNX $5.10
- Average True Range (ATR)
- TITN 0.62
- MGNX 0.38
- MACD
- TITN -0.01
- MGNX -0.03
- Stochastic Oscillator
- TITN 36.07
- MGNX 22.18
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
About MGNX MacroGenics Inc.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).